Circulating endothelial progenitor cells in acromegaly

J Endocrinol Invest. 2013 Nov;36(10):825-30. doi: 10.3275/9020. Epub 2013 Jun 26.

Abstract

Background: Endothelial progenitor cells (EPCs), involved in the repairing mechanisms of vascular damage, are positively correlated to insulin-like growth factor I (IGF-I) concentrations in healthy adults. However, the levels of EPCs and their role in acromegalic patients have never been investigated.

Aim: We conducted a cross-sectional study in order to assess the levels of the different phenotypes of circulating EPC in acromegalic patients.

Subjects and methods: The study was performed at the Endocrinology Unit of Federico II University and at the Unit of Metabolic Diseases and Endocrinology of the Second University of Naples. Fifty-five acromegalic patients and 65 healthy controls were studied. EPCs were assessed by flow cytometry and IGF-I by immunoradiometric assay.

Results: Compared with subjects of the control group, acromegalic patients showed significantly higher levels of EPCs phenotypes expressing KDR antigen [KDR+, cells per 106 events, median and interquartile range, 44 (28-67) vs 23 (13-40), p=0.006; CD34+KDR+ 25 (18-38) vs 12 (8-17), p<0.001; CD133+KDR+ 17 (13-30) vs 8 (6-12), p<0.001; CD34+KDR+CD133+ 16 (12-25) vs 8 (6-10), p<0.001]. There was a positive correlations between CD34+KDR+CD133+ cells count and IGF-I in acromegaly group (r=0.79, p<0.001).

Conclusions: Acromegalic patients show higher circulating EPCs levels expressing KDR, positively correlated with IGF-I, suggesting a role for IGF-I in regulating the expression of this surface marker in the early phase of EPCs differentiation.

Publication types

  • Comparative Study

MeSH terms

  • Acromegaly / blood*
  • Acromegaly / pathology*
  • Adult
  • Biomarkers / metabolism*
  • Case-Control Studies
  • Cross-Sectional Studies
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology*
  • Female
  • Flow Cytometry
  • Follow-Up Studies
  • Humans
  • Insulin-Like Growth Factor I / metabolism
  • Male
  • Middle Aged
  • Prognosis
  • Radioimmunoassay
  • Stem Cells / metabolism
  • Stem Cells / pathology*

Substances

  • Biomarkers
  • Insulin-Like Growth Factor I